+1 700 888 1234
Effingerstrasse 40 3008 Bern Switzerland
Bristol Myers Squibb has released a new Press Release announcing that the European Medicines Agency (EMA) has validated the marketing authorization application for repotrectinib. Repotrectinib […]
Financial impact of lung cancer: A European perspective High risk of financial vulnerability after diagnosis: The majority of people impacted […]
November 14th – 15th in Amsterdam We are delighted to announce that Lung Cancer Europe (LuCE) is participating in a two-day meeting […]
LuCE present at the ESMO Congress 2023 October 20th-24th in Madrid, Spain Our president Anne-Marie Baird had an active participation […]
About the Organization Lungunion Austria The Lungunion Austria is a patient organization (NGO and self-aid organization) for people with airway […]
Join us for our upcoming webinar on “Coping with lung cancer diagnosis: Physical, social and emotional impact”.
🗓️ Date: 18 September 2023.
⏰ Time: 1-2 PM CET.
📍 Location: Online: LuCE social media channels.
consectetur adipisicing elit, sed do eiusmod tempor incididunt laboret dolore magna aliqua. Ut enim minim veniam quis nostrud exercitation ullamco laboris.
